An exploratory, randomised, open-label, two-period, crossover study in healthy subjects to evaluate the effect of SMP-028 on the pharmacokinetics of midazolam
An exploratory, randomised, open-label, two-period, crossover study in healthy subjects to evaluate the effect of ketoconazole on the pharmacokinetics of SMP-028
A randomised, double-blind, placebo-controlled, two-sequence, two-period, crossover study to evaluate the effect of SMP-028 on oral contraceptive pharmacokinetics in healthy female subjects
100 Clinical Results associated with Dainippon Sumitomo Pharma Europe LTd.
0 Patents (Medical) associated with Dainippon Sumitomo Pharma Europe LTd.
100 Deals associated with Dainippon Sumitomo Pharma Europe LTd.
100 Translational Medicine associated with Dainippon Sumitomo Pharma Europe LTd.